Document is current
Any future updates will be listed below
-
Authors
Barmettler, Gabi
Leonard, Saskia
Giannakou, Andreas
Park, Ko Un
Smith, Claire E.
Mittendorf, Elizabeth A.
King, Tari A.
Kantor, Olga
- License Information
-
More Information
Article History
First Online: 22 January 2026
Disclosure
: EAM reports compensated service on scientific advisory boards for AstraZeneca, BioNTech, and Merck; uncompensated service on steering committees for Bristol Myers Squibb and Roche/Genentech; speaker’s honoraria and travel support from Merck Sharp & Dohme; institutional research support from Roche/Genentech (via SU2C grant) and Gilead; research funding from Susan Komen for the Cure for which she serves as a Scientific Advisor; and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors. TAK reports speaker honoraria for Exact Sciences, compensated service on the FES Steering Committee for GE Healthcare, compensated service for advisory board role for Veracyte, and compensated service as faculty for PrecisCa cancer information service. The remaining authors report no conflicts of interest.
